Keyphrases
Neuromyelitis Optica Spectrum Disorder (NMOSD)
100%
Human Leukocyte Antigen Haplotype
100%
Rare Variants
100%
Human Leukocyte Antigen
18%
New Human Leukocyte Antigen Allele
18%
DRB1
18%
Human Leukocyte antigen-A
18%
Complement Pathway
18%
Belgrade
18%
Autoimmune Disease
9%
Genetic Variants
9%
Disease Risk
9%
Family Members
9%
Autoimmunity
9%
Control Approach
9%
HLA-DQB1
9%
Diagnostic Criteria
9%
Aquaporin-4 (AQP4)
9%
Serbia
9%
Neurodegenerative Mechanisms
9%
Antibody to aquaporin-4
9%
In Silico Modeling
9%
Retrospective Case
9%
Autoimmune Mechanism
9%
Inherited Variants
9%
Haplotype Analysis
9%
Potassium Channel Genes
9%
Deleterious Variants
9%
Drug Target
9%
Exome Sequencing
9%
Nervous System Diseases
9%
Potassium Channel
9%
Human Genetic Variation
9%
Immunology and Microbiology
Human Leukocyte Antigen
100%
Haplotype
100%
Neuromyelitis Optica
100%
Allele
27%
Potassium Channels
18%
Aquaporin
18%
Population
9%
Genetic Variability
9%
Autoimmunity
9%
Autoimmune Disease
9%
Computer Model
9%
Whole Exome Sequencing
9%
Monospecific Antibody
9%
Genetic Variation
9%
Central Nervous System
9%
Biochemistry, Genetics and Molecular Biology
Human Leukocyte Antigen
100%
Haplotype
100%
Allele
37%
Potassium Channel
25%
Aquaporin 4
25%
Population
12%
Genetic Divergence
12%
Autoimmunity
12%
Computer Model
12%
Exome Sequencing
12%
Monospecific Antibody
12%
Genetic Variation
12%
Human Genetics
12%
Neuroscience
Neuromyelitis Optica
100%
Human Leukocyte Antigen
100%
Haplotype
100%
Aquaporin 4
18%
Potassium Channel
18%
Autoimmune Disease
9%
Genetic Variation
9%
Central Nervous System
9%
Exome Sequencing
9%